Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines May 25, 1999 No Comments
MMP inhibitor MMI-270 tested in cancer patients in combination with 5-FU/folinic acid May 24, 1999 No Comments
Compounds in development at Shionogi reverse oncogene-induced cell transformation May 24, 1999 No Comments
Positive findings from phase I trial of LY-353381 reported at ASCO meeting, lead to phase II study May 21, 1999 No Comments
First proteasome inhibitor in clinical development profiled at oncology meeting May 20, 1999 No Comments
Favorable pharmacokinetic, safety and efficacy profile for FMdC in phase I; phase II trials begin May 20, 1999 No Comments
RSS